Original Source(s)
Related Content
FDA approves serial liquid biopsy testing
In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.
September 8, 2026
-
2 min
Fallowed Fields Tied to Valley Fever
California surveillance data reveal associations between land use and coccidioidomycosis incidence
September 9, 2026
-
3 min
Neural Model Maps Ebola’s Spread
Simulation-based inference estimated transmission patterns from surveillance and genomic data
September 10, 2026
-
3 min
